Gemer 2 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 2mg and Metformin 500mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues, contributing to better glucose uptake and utilization. The combination of these two agents provides complementary mechanisms of action, resulting in effective reduction of blood glucose levels in patients inadequately controlled by diet and exercise alone. Gemer 2 Tablet PR is typically prescribed as part of a comprehensive diabetes management plan that includes lifestyle modifications such as diet and physical activity. It is important to monitor blood glucose levels regularly to assess therapeutic response and adjust dosage accordingly. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, which often diminish with continued use. Caution is advised in patients with renal or hepatic impairment, and contraindications include diabetic ketoacidosis and hypersensitivity to either component. This medication should be used under medical supervision to optimize diabetes control and minimize potential adverse effects.